Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
Niendorf
H P
HP
Clinical Research and Development Diagnostics, Schering AG, Berlin, Germany.
Alhassan
A
A
Geens
V R
VR
Clauss
W
W
D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects*; D004338:Drug Combinations; D019786:Gadolinium DTPA; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000009:adverse effects*; D009942:Organometallic Compounds / Q000009:adverse effects*; D004369:Pentetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA